• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biotricity Inc (NQ: BTCY )

    0.4631 UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 0.4631
    Bid (Size) 0.4300 (2)
    Ask (Size) 0.4400 (5)
    Prev. Close 0.4631
    Today's Range 0.4631 - 0.4631
    52wk Range 0.4631 - 1.670
    Shares Outstanding 22,454,644
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    SWK Holdings Provides Portfolio Update
    Via ACCESSWIRE
    Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins
    Via ACCESSWIRE

    Performance

    YTD
    -60.76%
    -60.76%
    1 Month
    N/A
    N/A
    3 Month
    N/A
    N/A
    6 Month
    -61.41%
    -61.41%
    1 Year
    -52.88%
    -52.88%

    More News

    Read More
    Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States
    Via ACCESSWIRE
    Biotricity Kicks off Another Pilot Program with a Major Hospital System that Services over 800K Individuals
    Via ACCESSWIRE
    Biotricity Reports Continued Margin Improvement and Reduced Losses in its First Quarter Fiscal Year 2025
    Via ACCESSWIRE
    BTCY Stock Earnings: Biotricity Reported Results for Q1 2025
    Via InvestorPlace
    Biotricity Launches HeartSecure: Immediate, At-Home Cardiac Screening Now Available
    Via ACCESSWIRE
    Biotricity Provides Year-End Guidance with Expectations to Meet Analyst Revenue Target and Beating Loss and Margin Targets
    Via ACCESSWIRE
    LOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESSWIRE
    Biotricity Announces Continued Margin Improvement Driven by its Proprietary AI Cloud
    Via ACCESSWIRE
    Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESSWIRE
    SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
    Via ACCESSWIRE
    Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESSWIRE
    Biotricity Announces Accelerated Path to EBITDA Positive
    Via ACCESSWIRE
    Biotricity Adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program
    Via ACCESSWIRE
    BTCY Stock Earnings: Biotricity Beats EPS, Misses Revenue for Q4 2024
    Via InvestorPlace
    Biotricity Reports Strong Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses for Fiscal Year 2024, Accelerating the Company's Path to Profitability
    Via ACCESSWIRE
    Biotricity to Host Fourth Quarter and Fiscal Year 2024 Financial Results and Business Update Call on June 27
    Via ACCESSWIRE
    Biotricity Launches Direct-to-Consumer Heart Health Screening Service, HeartSecure, Making Heart Health Services Accessible in Response to the #1 Global Killer, Poising Company to Access the Growing Home Diagnostics Market
    Via ACCESSWIRE
    Biotricity Preferred Shareholders Show Increased Commitment and Support of the Company by Converting Almost All Preferred A Shares into Restricted Common Stock
    Via ACCESSWIRE
    Biotricity Announces the Upcoming Launch of the First-Ever Direct-to-Patient Cardiac Screening Service, Targeting the $1.05B Home Heart Health Market
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Biotricity Expands Market Reach to Pulmonary and Neurology Fields Through Latest Partnerships with Two Leading Home-Based Diagnostic Companies
    Via ACCESSWIRE
    Biotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest from Existing and New Customers
    Via ACCESSWIRE
    Biotricity Launches Major Cardiac Monitoring Pilot Program in a Hospital System Comprised of 9 Hospitals and 10 Clinics
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.